ZNRD2-AS1

Across TCGA pan-cancer cohorts, ZNRD2-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated ZNRD2-AS1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher ZNRD2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ZNRD2-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and PAAD show a favorable association.

UCS, KICH, and ACC are the cancer types where ZNRD2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Median	III,IV	0.788	0.380	<.001	102	view →
KICH	DFS	Median	III,IV	0.322	0.942	.002	85	view →
ACC	DFS	Median	All	0.268	0.634	<.001	46	view →
KIRC	DFS	Quartile	IV	0.154	0.552	.001	38	view →
UVM	DFS	Tertile	III,IV	0.331	0.890	<.001	37	view →
PAAD	DFS	Median	All	0.377	0.200	.006	29	view →
READ	OS	Quartile	II,III,IV	1.000	0.279	.005	22	view →
MESO	DFS	Median	All	0.233	0.571	.012	18	view →
LIHC	OS	Median	All	0.717	0.829	.003	18	view →
COAD	DFS	Quartile	III,IV	0.325	0.755	.007	16	view →
PRAD	DFS	Median	All	0.708	0.876	.001	16	view →
ESCA	DFS	Median	II,III,IV	0.409	0.555	.034	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

ZNRD2-AS1–UCS (OS)

Open the UCS breakdown →